C
GSK plc GSK
$38.40 $0.441.16% NYSE
Recommendation
Prev Close
$38.40
Volume
9,566
Avg Vol (90D)
5,476,127
Market Cap
$76.79B
Dividend & Yield
$1.58(4.11%)
52-Week Range
$31.72 - $45.80
P/E (TTM)
39.80
EPS (TTM)
$0.9648
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Merck: 4 No-Brainer Reasons to Buy This Dip
2/10/2025 - MarketBeat
Vestal Point Capital LP Has $33.82 Million Position in GSK plc (NYSE:GSK)
5/21/2025 - MarketBeat
Soleus Capital Management L.P. Sells 27,390 Shares of GSK plc (NYSE:GSK)
5/21/2025 - MarketBeat
Visionary Wealth Advisors Buys 10,178 Shares of GSK plc (NYSE:GSK)
5/21/2025 - MarketBeat
1,084,130 Shares in GSK plc (NYSE:GSK) Bought by Woodline Partners LP
5/21/2025 - Ticker Report
Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)
5/21/2025 - TipRanks Financial Blog
Gabriel India Ltd leads gainers in 'A' group
5/21/2025 - Business Standard - Markets & Investing
Pharma shares in focus; GSK, Jubilant, Eris, Gland, Torrent rally up to 8%
5/21/2025 - Business Standard - Markets & Investing
Trump's MFN policy seeks parity with branded drug pricing in OECD nations
5/20/2025 - Seeking Alpha - Healthcare
Akero surges after report on plans for potential sale
5/20/2025 - Seeking Alpha - Healthcare
HHS says 'taking immediate steps to implement' Trump drug pricing order
5/20/2025 - TipRanks Financial Blog
CMS demands on drug pricing 'extreme,' 'highly problematic,' says Leerink
5/20/2025 - TipRanks Financial Blog
Gilead Sciences vs GSK: Which HIV Drugmaker is a Smarter Buy Now?
5/20/2025 - Zacks Investment Research
GSK Executives Acquire ADSs Through Dividend Reinvestment
5/20/2025 - TipRanks Financial Blog
Ionis' Tryngolza Cuts Triglyceride Levels in Late-Stage Study
5/20/2025 - Zacks Investment Research
WHO member states adopt pandemic agreement without U.S.
5/20/2025 - Seeking Alpha - Healthcare
Tang Capital Management LLC Sells 50,000 Shares of GSK plc (NYSE:GSK)
5/20/2025 - MarketBeat
Market Today: Mixed Reactions Amid Corporate Developments
5/20/2025 - GuruFocus
Why this FTSE 100 pharma stock is one for investors to consider right now
5/20/2025 - The Motley Fool UK
GSK Funds Lifetime Original Movie On Meningitis B
5/19/2025 - MediaPost Marketing News
Regeneron acquires bankrupt 23andMe, pledges ethical use of genetic data
5/19/2025 - Invezz News
GSK or ACAD: Which Is the Better Value Stock Right Now?
5/19/2025 - Zacks Investment Research
Why These 4 Women-Run Companies Deserve a Spot in Your Portfolio?
5/19/2025 - Zacks Investment Research
The Zacks Analyst Blog Highlights Bayer, Novo Nordisk, GSK, Merck and AbbVie
5/19/2025 - Zacks Investment Research
After a Reset Year, Is Moderna Stock Poised for a Comeback?
1/22/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$40.23B
EBITDA (TTM)
$11.61B
EBIT (TTM)
$7.85B
Net Income (TTM)
$3.98B
Balance Sheet
Total Assets (Q)
$78.43B
Total Debt (Q)
$23.81B
Total Liabilities (Q)
$60.79B
Book Value Per Share (Q)
$4.48
Cash Flow
Cash from Operations (TTM)
$8.63B
Cash from Investing (TTM)
-$2.85B
Cash from Financing (TTM)
-$3.61B
Net Change in Cash (TTM)
$2.11B
Filings
Filing Date
Wednesday, April 30, 2025
Period Date
Monday, March 31, 2025
Next Filing
End of July (est)
Price History
Loading...
Beta
0.31
7-Day Total Return
3.92%
30-Day Total Return
13.79%
60-Day Total Return
1.24%
90-Day Total Return
18.65%
Year to Date Total Return
15.64%
1-Year Total Return
-9.90%
2-Year Total Return
17.66%
3-Year Total Return
-4.97%
5-Year Total Return
14.71%
52-week Low
Jan 14, 2025 - $31.72
52-week High
May 22, 2024 - $45.80
Valuation
Market Cap
$76.79B - Large Cap
Enterprise Value
$94.75B
Price/Sales (TTM)
3.95
Price/Book (Q)
8.57
Dividends and Shares
Shares Outstanding
4.14B
Dividend Per Share (Most Recent)
$0.4216
Dividend Per Share (TTM)
$1.58
Corporate Info
Website
www.gsk.com
Phone Number
44 20 8047 5000
Address
79 New Oxford Street
London, WC1A 1DG
Country
United Kingdom
Year Founded
1715
Business Description
Sector
--
Industry
--
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United... more
NYSE 05/20/2025 4:00PM Eastern Quotes delayed